Immunovant
IMVT
#2555
Rank
โ‚น641.55 B
Marketcap
โ‚น3,100
Share price
-0.12%
Change (1 day)
47.77%
Change (1 year)

Earnings for Immunovant (IMVT)

Earnings in 2026 (TTM): -โ‚น52.11 Billion

According to Immunovant's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น45.54 Billion a decrease over its 2024 earnings that were of -โ‚น37.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Immunovant from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น52.11 Billion14.44%
2025 -โ‚น45.54 Billion20.23%
2024 -โ‚น37.88 Billion59.79%
2023 -โ‚น23.71 Billion32.6%
2022 -โ‚น17.88 Billion39.55%
2021 -โ‚น12.81 Billion37.3%
2020 -โ‚น9.33 Billion780.74%
2019 -โ‚น1.06 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.6 Billion-72.41%๐Ÿ‡บ๐Ÿ‡ธ USA